Microglial dysfunction and NLRP3 inflammasome signaling in Alzheimer’s disease: mechanistic insights into neuroinflammation and neurodegeneration

作者
Gayatri C Pawar, Ujwala D Patil, Farheen M Pathan,Almas Meheboob Pathan
标识
DOI:10.55522/ijti.v4i4.0169
摘要

Alzheimer's disease (AD) is a progressively debilitating neurodegenerative condition characterized by the accumulation of amyloid-β (Aβ), tau pathology, synaptopathy, and neuron loss. Recent studies suggest that Neuroinflammation is a critical part of the disease process rather than an accompanying feature of the mentioned pathological changes. Microglia, the immune cells of the central nervous system, respond to amyloid-beta and pathological tau and exhibit functional alterations leading to the transition from their initial anti-inflammatory and neuroprotective function to chronic inflammation. Persistent activation of microglia is linked with the inability to clear abnormal proteins, excessive complement-dependent synaptic loss, secretion of cytokines, activation of astrocytes, and neuronal damage. Various inflammatory pathways play their roles, and one of the most prominent is the NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome. The activation of the NLRP3 inflammasome leads to the recruitment of apoptosis-associated speck-like protein containing CARD (ASC) and caspase-1 activation, followed by interleukin-1β (IL-1β) and IL-18 maturation and gasdermin D (GSDMD) cleavage, contributing to pyroptosis and inflammatory processes. The current review will cover changing role of microglia in AD progression, interactions between Aβ, tau, and inflammatory signaling pathways as well as molecular mechanisms of NLRP3 Inflammasome activation. Furthermore, it will discuss new approaches that could be used for modulations of NLRP3 inflammasome signaling, including selective small molecule inhibition, caspase-1 targeting, natural compound use, repurposed drugs, and new drug delivery systems. Specifically, the ability to cross blood-brain barrier (BBB), safety, translational challenges, and dissimilarity between animal models and humans' AD will be discussed in this context. Overall, targeting dysregulated Neuroinflammation, including NLRP3 inflammasome activation, could serve as an alternative approach to existing protein-directed treatment methods.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
dde发布了新的文献求助10
刚刚
千桑客完成签到,获得积分10
刚刚
咩咩哭包完成签到 ,获得积分10
1秒前
枕文观汐完成签到 ,获得积分10
1秒前
1秒前
787878完成签到,获得积分10
1秒前
蓝星花完成签到 ,获得积分10
2秒前
李健的小迷弟的应助被Star1983采纳,获得10
2秒前
拉长的远山完成签到,获得积分10
3秒前
Jason完成签到,获得积分10
3秒前
阿峰完成签到,获得积分10
3秒前
水之虞完成签到,获得积分10
3秒前
TrDoubleE完成签到 ,获得积分10
4秒前
畅快的胡萝卜完成签到,获得积分10
4秒前
wangyaofeng完成签到,获得积分10
4秒前
4秒前
yeroumu3zhi完成签到,获得积分0
4秒前
lingmo完成签到,获得积分10
5秒前
tianX发布了新的文献求助10
5秒前
灵巧若颜完成签到,获得积分10
6秒前
APS完成签到,获得积分10
7秒前
易安完成签到,获得积分10
8秒前
8秒前
金澜完成签到 ,获得积分10
9秒前
KaMiii完成签到,获得积分10
9秒前
水水完成签到 ,获得积分10
9秒前
苏东方完成签到,获得积分10
9秒前
null的应助被CharlieYue采纳,获得10
9秒前
陵亚未发布了新的文献求助10
9秒前
科研通AI6.4的应助被CharlieYue采纳,获得10
9秒前
科研通AI6.2的应助被CharlieYue采纳,获得10
10秒前
思源的应助被MM采纳,获得10
10秒前
萝卜完成签到,获得积分10
10秒前
北纬三十度完成签到,获得积分10
10秒前
wbbb完成签到,获得积分10
10秒前
我又双叒叕窜了完成签到,获得积分10
11秒前
fdj3121完成签到,获得积分10
11秒前
11秒前
Ace完成签到,获得积分10
12秒前
东方元语完成签到,获得积分0
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159212
求助须知:如何正确求助?哪些是违规求助? 9554678
关于积分的说明 21720538
捐赠科研通 7748887
什么是DOI,文献DOI怎么找? 3427184
关于科研通互助平台的介绍 2552092
邀请新用户注册赠送积分活动 2471464